accountit a little less attractive to any potential acquirer not named "Glaxo." Keep in mind, though, that Eli Lilly bought ImClone Systems knowing that it would have to deal with Bristol-Myers to market Erbitux, so this reservation's still not a dealbreaker....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Who's Next? 5 Potential Biotech Takeover Targets
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account